Susceptibility-guided bismuth quadruple therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Susceptibility-guided bismuth quadruple therapy, covering 2024-11-13 to 2024-11-13. Get the full timeline:
Most recent: Clinical Trial Update: 14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection [Phase 4]